NovaBone Products, a leading biologics medical device company, announced that it has received the Brazilian ANVISA Good Manufacturing Practices (GMP) medical device certificate. ANVISA is Brazil’s equivalent to the US Federal Drug Administration (FDA) and is responsible for the oversight of all medical device and pharmaceuticals in the Brazilian market. The entire portfolio of NovaBone dental and orthopaedic products is now available for Brazilian distribution.
“This important certificate extends our distribution to the largest market in South America,” said Mr. Art Wotiz, President of NovaBone Products. “The ANVISA GMP medical device certificate is another recognition of our commitment to quality and developing safe and effective leading-edge products for the global market.”
NovaBone Strip Bone Graft is a sterile bone graft composed of purified fibrillar collagen and resorbable bioactive synthetic granules. This is one of several collagen devices engineered by NovaBone Products. (Photo: Business Wire)